Suchergebnisse - "Shinoda, Shuhei"

PubPharm (26)

1

Retraction Note : Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2023

von Amano, S. | Kaino, S. | Shinoda, S. | +7

RetractionOf: BMC Cancer. 2020 Jul 22;20(1):681. - PMID 32698792

2

Interferon-expressing oncolytic adenovirus + chemoradiation inhibited pancreatic cancer growth in a hamster model

enthalten in: Cancer science | 2023

von Shinoda, S. | Sharma, N. | Nakamura, N. | +5

3

Correction : Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2023

von Amano, S. | Kaino, S. | Shinoda, S. | +7

ErratumFor: BMC Cancer. 2020 Jul 22;20(1):681. - PMID 32698792

4

Correction: Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2023

von Amano, S. | Kaino, S. | Shinoda, S. | +7

5

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia

enthalten in: DEN open | 2023

von Amano, S. | Suenaga, S. | Hamamoto, K. | +10

6

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia

enthalten in: DEN Open | 2023

von Amano, S. | Suenaga, S. | Hamamoto, K. | +10

7

Obesity and Pancreatic Cancer : Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery

enthalten in: Biomedicines | 2022

von Shinoda, S. | Nakamura, N. | Roach, B. | +3

8

Fatty acid binding protein 4 regulates pancreatic cancer cell proliferation via activation of nuclear factor E2-related factor 2

enthalten in: Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery | 2022

von Wirth, K. | Shinoda, S. | Sato-Dahlman, M. | +4

CommentIn: Surg Obes Relat Dis. 2022 Apr;18(4):493-494. - PMID 35131198

9

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2020

von Amano, S. | Kaino, S. | Shinoda, S. | +7

ErratumIn: BMC Cancer. 2023 Jun 23;23(1):582. - PMID 37353751

10

Invasion inhibition in pancreatic cancer using the oral iron chelating agent deferasirox

enthalten in: BMC cancer | 2020

von Amano, S. | Kaino, S. | Shinoda, S. | +7